CONTEXT The Food and Drug Administration (FDA) Safety and Innovation Act has recently relaxed conflict-of-interest rules for FDA advisory committee members, but concerns remain about the influence of members' financial relationships on the FDA's drug approval process. Using a large newly available data set, this study carefully examined the relationship between the financial interests of FDA Ce...

1. Grohskopf LA, Shay DK, Shimabukuro TT, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2013–14 influenza season. MMWR Recomm Rep 2013; 62:1–43. 2. Varricchio F, Iskander J, DeStefano F, et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Inf...

The purpose of this document is to provide the Antiviral Products’ Advisory Committee with a summary of FDA analyses of data submitted in support of a request for accelerated approval of maraviroc, the first in a new class of antiretroviral drugs called CCR5 receptor antagonists. During the Advisory Committee meeting to be held on April 24, 2007, the Committee will be asked to consider the safe...

The material in this report originated in the National Center for Infectious Diseases, Rima F. Khabbaz, MD, Director; Division of Healthcare Quality Promotion, Denise M. Cardo, MD, Director; Division of Viral and Rickettsial Diseases, Steve Monroe, PhD, Acting Director; and National Immunization Program, Anne Schuchat, MD, Director; Epidemiology and Surveillance Division, Alison Mawle, PhD, Act...

Increases in the number and cost of vaccines routinely recommended for children and adolescents have raised concerns about the ability of the current systems for vaccine financing and delivery to ensure that all children and adolescents have access to all routinely recommended vaccinations without financial barriers. The National Vaccine Advisory Committee (NVAC) was chartered in 1988 to advise...

The material in this report originated in the National Center for Infectious Diseases, Rima F. Khabbaz, MD, Director; Division of Healthcare Quality Promotion, Denise M. Cardo, MD, Director; Division of Viral and Rickettsial Diseases, Steve Monroe, PhD, Acting Director; and National Immunization Program, Anne Schuchat, MD, Director; Epidemiology and Surveillance Division, Alison Mawle, PhD, Act...

With cost of vaccines steadily increasing, recommendations of the Advisory Committee on Immunization Practices (ACIP) have growing economic implications for the public. We used semi-structured telephone interviews to assess the knowledge, attitudes, and practices of the 15 voting members of the 2006-2007 ACIP regarding the use of economic information by the committee in their deliberations abou...

The National Advisory Committee on Immunization (NACI) provides Health Canada with ongoing and timely medical, scientific, and public health advice relating to immunization. Health Canada acknowledges that the advice and recommendations set out in this statement are based upon the best current available scientific knowledge and is disseminating this document for information purposes. People adm...